Skip to content

Posts tagged ‘’


rival Eli Lilly, which has developed it as a canada goose uk

8 bln Sanofi insulin wins EU green light

LONDON, June 27 (Reuters) European regulators have for the first time recommended approval of a cheap Canada Goose copycat insulin for diabetics, posing a threat to French drugmaker Sanofi canada goose black friday sale whose top selling Lantus is now set to face a cheaper rival in 2015. rival Eli Lilly, which has developed it as a canada goose uk outlet so called biosimilar version of Sanofi $8 billion a year Lantus, or insulin glargine.

The canadian goose jacket green light from the European Medicine Agency (EMA) for Lilly and its buy canada goose jacket cheap partner Boehringer Ingelheim marks another step forward for biosimilar medicines, which are copies of Canada Goose sale biotech drugs that promise canada goose uk shop to cut the Canada Goose online cost of treatment.

Biosimilar versions of drugs such as uk canada goose outlet EPO, used to boost red blood cells, and human growth hormone, canada goose clearance for treating certain growth abnormalities, have been available for several years, while the first antibody based biosimilar, for rheumatoid arthritis, was approved in Europe last September.

The evolution of such medicines represents a long term challenge to makers of complex Canada Goose Parka biological drugs, which cheap canada goose uk are given by injection and have been largely immune to generic competition up until now.

Industry analysts expect Lilly Canada Goose Jackets version of insulin glargine to be priced significantly lower than Lantus, Canada Goose Outlet in order to attract canada goose coats patients and healthcare providers.

Enrique Conterno, president of Lilly diabetes division, said his company product would provide important new option for the millions of patients in the EU canada goose coats on sale who need basal Canada Goose Online insulin to help manage their diabetes.

Basal insulin is intended to provide long lasting blood sugar control between meals and at night. Lantus currently dominates the market for such products, out selling a rival treatment called Levemir from Denmark Novo Nordisk.

Because biotech drugs are made from living cells it is impossible to manufacture exact uk canada Canada Goose online goose copies, as happens with simple chemical medicines, so European regulators have devised an approval canada goose clearance sale process for products that are similar enough to do the job.

The EMA, which announced its recommendation on Friday at the end of a canada goose monthly meeting of experts in London, said clinical studies had shown Abasria to have a comparable quality, safety and efficacy profile to Lantus.

CASH COW The positive recommendation from the agency Committee for Medicinal Products for buy canada goose jacket Human Use (CHMP) will now go to the European Commission for final approval, but Lilly will not be able to launch immediately as Sanofi still has patent protection.

With the European compound patent on Lantus set to expire in May 2015 in most markets, Deutsche Bank analyst Mark Clark said he expected Lilly to start rolling out the drug for type 1 and type 2 diabetes from around the middle of next year.

Although a challenge for Sanofi, Clark said the financial impact of European approval of biosimilar Lantus would be limited as Europe accounted for only 14 percent of the product global sales of 5.7 billion euros ($7.8 billion) last year.

Sanofi is also developing an improved successor to canada goose uk black friday its long running cash cow. This follow on, Toujeo, could also be ready for launch in mid 2015 and Sanofi is expected to work hard to Canada Goose Coats On Sale shift patients on to the new canada goose factory sale medicine. Lilly drug was canada goose store previously known as LY2963016.